Two of the most common causes of inflammatory enteritis are Campylobacter fetus subsp. jejuni and Shigella species. No single antimicrobial agent is recommended for treatment of both diseases. Erythromycin is used to treat C. fetus subsp. jejuni infections but has not been studied in shigellosis. For this reason, we determined the susceptibility of 22 strains of Shigella to erythromycin and found that Shigella species are susceptible to concentrations of erythromycin which are obtainable in stool.
Two frequent causes of inflammatory enteritis worldwide are Campylobacter fetus subsp. jejuni (C. jejuni) and Shigella species (2, 3, 5) . Both can produce acute dysentery with fever, tenesmus, and bloody mucoid stools with numerous fecal polymorphonuclear neutrophils (2, 6) . A definitive diagnosis requires several days to isolate and identify the organism by stool culture, a process that is not available in many parts of the developing world. Although appropriate antimicrobial therapy for shigellosis and campylobacter infection is indicated (5, 10) Laboratories, North Chicago, Ill.) ranging from 4 to 1,000 ,ug/ml in duplicate microtiter plates. The minimal lethal concentration was determined at 24 h by methods previously described (9) . Agar dilution tests were performed by using Mueller-Hinton agar (BBL Microbiology Systems) plates that contained 0.8 to 500 ,ug of erythromycin per ml. Inoculation with 105 and 10' CFU/ml was performed with a Steers replicator. Incubation was carried out at 37°C in 5% C02-95% room air.
The mean inhibitory concentration and minimum lethal concentration data are presented in 
